Literature DB >> 31276948

Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome.

M Martin Jensen1, Wanjian Jia2, Austin J Schults2, Kyle J Isaacson1, Douglas Steinhauff1, Bryant Green1, B Zachary3, Joseph Cappello4, Hamidreza Ghandehari5, Siam Oottamasathien6.   

Abstract

Interstitial cystitis (IC), also known as painful bladder syndrome, is a debilitating chronic condition with many patients failing to respond to current treatment options. Rapid clearance, mucosal coating, and tight epithelium create strong natural barriers that reduce the effectiveness of many pharmacological interventions in the bladder. Intravesical drug delivery (IDD) is the administration of therapeutic compounds or devices to the urinary bladder via a urethral catheter. Previous work in improving IDD for IC has focused on the sustained delivery of analgesics within the bladder and other small molecule drugs which do not address underlying inflammation and bladder damage. Therapeutic glycosaminoglycans (GAG) function by restoring the mucosal barrier within the bladder, promoting healing responses, and preventing irritating solutes from reaching the bladder wall. There is an unmet medical need for a therapy that provides both acute relief of symptoms while alleviating underlying physiological sources of inflammation and promoting healing within the urothelium. Semi-synthetic glycosaminoglycan ethers (SAGE) are an emerging class of therapeutic GAG with intrinsic anti-inflammatory and analgesic properties. To reduce SAGE clearance and enhance its accumulation in the bladder, we developed a silk-elastinlike protein polymer (SELP) based system to enhance SAGE IDD. We evaluated in vitro release kinetics, rheological properties, impact on bladder function, pain response, and bladder inflammation and compared their effectiveness to other temperature-responsive polymers including Poloxamer 407 and poly(lactic-co-glycolic acid)-poly(ethylene glycol). SAGE delivered via SELP-enhanced intravesical delivery substantially improved SAGE accumulation in the urothelium, provided a sustained analgesic effect 24 h after administration, and reduced inflammation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glycosaminoglycan; Interstitial cystitis; Intravesical drug delivery; Painful bladder syndrome; Silk-elastinlike protein; Temperature-responsive polymer

Mesh:

Substances:

Year:  2019        PMID: 31276948      PMCID: PMC6638575          DOI: 10.1016/j.biomaterials.2019.119293

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  57 in total

Review 1.  Intravesical liposome therapy for interstitial cystitis.

Authors:  Pradeep Tyagi; Mahendra Kashyap; Tsuyoshi Majima; Naoki Kawamorita; Tsuyoshi Yoshizawa; Naoki Yoshimura
Journal:  Int J Urol       Date:  2017-03-04       Impact factor: 3.369

Review 2.  Temperature-Responsive Smart Nanocarriers for Delivery Of Therapeutic Agents: Applications and Recent Advances.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Alireza Ghasemi; Mohammad Amiri; Mohsen Bahrami; Hedieh Malekzad; Hadi Ghahramanzadeh Asl; Zahra Mahdieh; Mahnaz Bozorgomid; Amir Ghasemi; Mohammad Reza Rahmani Taji Boyuk; Michael R Hamblin
Journal:  ACS Appl Mater Interfaces       Date:  2016-08-11       Impact factor: 9.229

3.  Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

Authors:  Wanjian Jia; Austin J Schults; Mark Martin Jensen; Xiangyang Ye; Jeremiah A Alt; Glenn D Prestwich; Siam Oottamasathien
Journal:  Am J Clin Exp Urol       Date:  2017-09-01

4.  PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate.

Authors:  Yuan Gao; Yan Sun; Fuzheng Ren; Shen Gao
Journal:  Drug Dev Ind Pharm       Date:  2010-10       Impact factor: 3.225

5.  Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial.

Authors:  Edward L Davis; Samar R El Khoudary; Evelyn O Talbott; Josephine Davis; Lisa J Regan
Journal:  J Urol       Date:  2007-11-14       Impact factor: 7.450

6.  Treatment of interstitial cystitis with intravesical heparin.

Authors:  C L Parsons; T Housley; J D Schmidt; D Lebow
Journal:  Br J Urol       Date:  1994-05

7.  Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results.

Authors:  Joseph C Cappelleri; Andrew G Bushmakin; Gergana Zlateva; Alesia Sadosky
Journal:  Pain Pract       Date:  2009-06-22       Impact factor: 3.183

8.  Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan.

Authors:  Won Yong Lee; Justin R Savage; Jianxing Zhang; Wanjian Jia; Siam Oottamasathien; Glenn D Prestwich
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

9.  A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis.

Authors:  Justin R Savage; Abigail Pulsipher; Narayanam V Rao; Thomas P Kennedy; Glenn D Prestwich; Maria E Ryan; Won Yong Lee
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

10.  Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation.

Authors:  Tingsheng Lin; Xiaozhi Zhao; Yifan Zhang; Huibo Lian; Junlong Zhuang; Qing Zhang; Wei Chen; Wei Wang; Guangxiang Liu; Suhan Guo; Jinhui Wu; Yiqiao Hu; Hongqian Guo
Journal:  Materials (Basel)       Date:  2016-12-12       Impact factor: 3.623

View more
  6 in total

1.  Translational Development of a Silk-Elastinlike Protein Polymer Embolic for Transcatheter Arterial Embolization.

Authors:  Øyvind Hatlevik; Martin Jensen; Douglas Steinhauff; Xiaomei Wei; Eugene Huo; Jolanta Jedrzkiewicz; Joseph Cappello; Darwin Cheney; Hamidreza Ghandehari
Journal:  Macromol Biosci       Date:  2022-01-02       Impact factor: 4.979

2.  Periostin Attenuates Cyclophosphamide-induced Bladder Injury by Promoting Urothelial Stem Cell Proliferation and Macrophage Polarization.

Authors:  Zhihong Chen; Liyong Liu; Yunhua Chen; Minjie Liu; Andy Peng Xiang; Chunhua Deng; Mei Hua Jiang
Journal:  Stem Cells Transl Med       Date:  2022-06-22       Impact factor: 7.655

Review 3.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

4.  Location of stimuli-responsive peptide sequences within silk-elastinlike protein-based polymers affects nanostructure assembly and drug-polymer interactions.

Authors:  Kyle J Isaacson; M Martin Jensen; Douglas B Steinhauff; James E Kirklow; Raziye Mohammadpour; Jason W Grunberger; Joseph Cappello; Hamidreza Ghandehari
Journal:  J Drug Target       Date:  2020-04-29       Impact factor: 5.121

5.  A dual-functional Embolization-Visualization System for Fluorescence image-guided Tumor Resection.

Authors:  M Martin Jensen; Zachary B Barber; Nitish Khurana; Kyle J Isaacson; Douglas Steinhauff; Bryant Green; Joseph Cappello; Abigail Pulsipher; Hamidreza Ghandehari; Jeremiah A Alt
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

6.  An Oligomeric Sulfated Hyaluronan and Silk-Elastinlike Polymer Combination Protects against Murine Radiation Induced Proctitis.

Authors:  Douglas Steinhauff; Mark Martin Jensen; Ethan Griswold; Jolanta Jedrzkiewicz; Joseph Cappello; Siam Oottamasathien; Hamidreza Ghandehari
Journal:  Pharmaceutics       Date:  2022-01-12       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.